Food and Drug Administration officials on Wednesday said Maharashtra’s Food and Drug Administration has seized stocks of a drug allegedly misleading to treat diabetes after raiding the headquarters of a drug distributor.
Food and Drug Administration Assistant Commissioner RP Chaudhari said drug inspectors from the agency raided the distributor’s headquarters in Dombivli on Tuesday on a tip-off and confiscated stocks worth Rs 25,000 of Amrit Noni D-plus, a drug the manufacturer makes unverified claims on its label about treating a disease diabetes mellitus;
He said the action was taken under the Medicines and Magical Cures (Disapproved Ads) Act 1954.
The FDA official said the label content on Amrit Noni D Plus is against the provisions of the law, adding that further investigation is underway.
“No one can make claims for the treatment of certain health disorders,” said Mr. Chaudhry. “Making such claims amounts to a violation of regulations.”
(Except for the headline, this story has not been edited by the NDTV crew and is published from a syndicated feed.)